Jun04
Novartis buys drug firm Protez for up to $400 mln
on June 4th, 2008 at 12:17 pmPosted In: News & Articles
ZURICH (Reuters) – Novartis has bought U.S. based Protez Pharmaceuticals in a deal worth up to $400 million, giving it rights to an antibiotic which could be used to fight superbugs such as MRSA, the Swiss drugmaker said. “(The) acquisition of Protez Pharmaceuticals provides rights to PZ-601 and further strengthens specialty medicines development portfolio in […] ↓ Read the rest of this entry…
Comment
